1-3 of 3
P. Fazi, MD
Close
Sort by
Journal Articles

High Levels of Tumor Load Reduction after Intensive Chemotherapy Favorably Affect the Prognosis of BCR/ABL+ ALL Adult Patients Receiving Imatinib Mesylate Alone as a Post-Consolidation Treatment According to the Italian GIMEMA LAL 0201/A Protocol.

G. Cimino, MD, L. Elia, PhD, Fabrizio Pane, MD, M. Vignetti, MD, P. Fazi, MD, S. Iacobelli, PhD, G. Meloni, MD, A. Vitale, MD, V. Martini, MD, G. Martinelli, MD, F. Di Raimondo, MD, M. Bonifacio, MD, F. Fabbiano, MD, G. Saglio, MD, M. Baccarani, MD, R. Foà, MD, F. Mandelli, MD
Journal: Blood
Blood (2006) 108 (11): 638.
https://doi.org/10.1182/blood.V108.11.638.638
Published: 2006
Journal Articles

Therapy-Related Myelodysplastic Syndrome (sMDS) /Acute Myelogenous Leukemia (sAML) in Acute Promyelocytic Leukemia (APL) Patients with Long-Lasting Molecular Remission: The GIMEMA Experience.

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, S. Gubbiotti, MD, E. Di Bona, MD, G. Specchia, PhD, A. Chiarenza, MD, R. Murru, MD, A.M. Carella, PhD, F. Ferrara, PhD, G. Rossi, MD, L. Melillo, MD, S. Sica, MD, R. Invernizzi, MD, G. Cimino, PhD, M.C. Petti, PhD, G. Avvisati, PhD, F. Lo-Coco, PhD, F. Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 884.
https://doi.org/10.1182/blood.V106.11.884.884
Published: 2005
Journal Articles

Long-Term Results of the GIMEMA LAP AIDA 0493 Amended Protocol in Elderly Patients with Acute Promyelocytic Leukemia (APL).

R. Latagliata, MD, M. Breccia, MD, P. Fazi, MD, M. Vignetti, MD, A. Cupri, MD, M. Sborgia, MD, D. Vincelli, MD, A. Candoni, MD, F. Salvi, MD, S. Rupoli, MD, G. Martinelli, MD, M.G. Kropp, MD, N. Di Rienzo, MD, V. Zampaglione, MD, A. Venditti, PhD, L. Melillo, MD, G. Cimino, PhD, M.C. Petti, MD, G. Avvisati, PhD, F. Lo Coco, PhD, F. Mandelli, PhD
Journal: Blood
Blood (2005) 106 (11): 885.
https://doi.org/10.1182/blood.V106.11.885.885
Published: 2005